Bird Marella principal Ariel Neuman recently spoke with STAT Articles regarding the criminal investigation of blood analysis startup, Theranos. The silicon valley based company is currently being investigated by the SEC and the U.S. Attorney’s Office for the Northern District of California, relating to the company’s inner workings and alleged misleading of investors about their technology.
While the SEC and the USAO have yet to file charges against Theranos, the company could face hefty fines and its executives could face jail time, if found of any wrongdoing.
Mr. Neuman added, “It’s often a hard line to draw, but [at the] end of the day, what the regulators are going to be looking for is: Is this something we can prove to be false?”
STAT Articles is a new national publication focused on finding and telling compelling stories about health, medicine, and scientific discovery. The publication produces daily Articles, investigative articles, and narrative projects in addition to multimedia features.
For more information, click here.
